HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Downregulation of Th17 cells and the related cytokines with treatment in Kawasaki disease.

Abstract
Given the inflammatory nature of Kawasaki disease (KD) and the pro-inflammatory properties of Th17, this study aimed to determine the frequency of Th17 cells and the levels of corresponding cytokines in acute phase of KD and to evaluate their alterations one and eight weeks after treatment. Th17 and the related cytokine levels were measured in 21 KD patients and 42 positive and negative controls, using flow cytometry and ELISA, respectively. Th17, IL-17, IL-22 and IL-23 were significantly higher (P<0.05) in patients compared with negative controls, but no significant differences (P>0.05) with the positive controls. Furthermore, Th17, IL-17, IL-22 and IL-23 were significantly higher in patients before treatment than those one and eight weeks after. Considering the downregulation of Th17 and its related cytokines with aspirin and intravenous immunoglobulin therapy implies the probable role of Th17 in KD pathogenesis.
AuthorsManoochehr Rasouli, Behzad Heidari, Mehdi Kalani
JournalImmunology letters (Immunol Lett) Vol. 162 Issue 1 Pt A Pg. 269-75 (Nov 2014) ISSN: 1879-0542 [Electronic] Netherlands
PMID25277751 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier B.V. All rights reserved.
Chemical References
  • Cytokines
  • Immunoglobulins, Intravenous
Topics
  • Child, Preschool
  • Cytokines (blood, metabolism)
  • Down-Regulation
  • Female
  • Humans
  • Immunoglobulins, Intravenous (therapeutic use)
  • Immunophenotyping
  • Infant
  • Leukocytes, Mononuclear (immunology, metabolism)
  • Lymphocyte Count
  • Male
  • Mucocutaneous Lymph Node Syndrome (diagnosis, drug therapy, immunology, metabolism)
  • Phenotype
  • Th17 Cells (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: